Drug Screening And Treatment Methods

Abstract

The invention relates to methods identify or characterize compounds that can be used to treat specified clinical disorders such as hyperglycemia and type 2 diabetes. Compounds that can be used in these methods include 4α-fluoro-17α-ethynylandrost-5-ene-3β,7β,17β-triol, 4α-fluoro-17α-ethynylandrost-5-ene-3β,7α,17β-triol, 4α-fluoro-17α-ethynylandrost-5-ene-3α,7β,17β-triol and 4α-fluoro-17α-ethynylandrost-5-ene-3β,17β-triol-7-one.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 10, 2012
  • Application: Nov 19, 2007
    US US 94266407 A
  • Priority: Nov 19, 2007
    US US 94266407 A
  • Priority: Nov 17, 2007
    US US 94193407 A
  • Priority: Feb 2, 2007
    US US 88805807 P
  • Priority: Jan 15, 2007
    US US 88500307 P
  • Priority: Nov 30, 2006
    US US 86804206 P
  • Priority: Nov 21, 2006
    US US 86670006 P
  • Priority: Nov 17, 2006
    US US 86639506 P

Download Citation


Sign in to the Lens

Feedback